Benitec Biopharma Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2019 Jun2020 Jun2021 Jun2022 Jun2023 Jun2024 Jun2025
Revenue & cost
Revenue 12.20M0.10M0.06M0.07M0.07M
Gross Profit 11.76M-0.08M-0.06M0.06M0.07M
Operating items
Research & Development 4.57M3.00M7.02M11.27M12.77M15.61M18.33M
Selling, General & Administrative 4.61M5.57M6.51M6.65M6.38M6.99M23.43M
Other Operating Expenses 0.43M-0.18M0.12M0.01M-0.11M
Operating Expenses 9.62M8.38M13.65M17.93M19.16M22.49M41.77M
Operating Income 2.58M-8.28M-13.60M-17.85M-19.08M-22.49M-41.77M
EBIT 2.58M-8.28M-13.60M-17.85M-19.08M-22.49M-41.77M
Non-operating items
Non Operating Investment Income -0.02M-0.00M0.02M-0.01M-0.00M-0.00M
Interest & Investment Income 0.12M0.06M-0.01M-0.03M-0.03M0.90M3.29M
Other Non Operating Income -0.07M-0.09M-0.33M-0.23M-0.41M-0.20M0.76M
Non Operating Income 0.03M0.03M-0.29M-0.35M-0.48M0.74M3.85M
Net income details
EBT 2.71M-8.22M-13.60M-17.89M-19.11M-21.59M-38.48M
Profit After Tax 2.61M-8.30M-13.90M-18.21M-19.60M-21.80M-37.92M
Income from Continuing Operations 2.71M-8.22M-13.60M-17.89M-19.11M-21.59M-38.48M
Consolidated Net Income 2.71M-8.22M-13.60M-17.89M-19.11M-21.59M-38.48M
Income towards Parent Company 2.71M-8.22M-13.60M-17.89M-19.11M-21.59M-38.48M
Preferred Dividend Payments 0.62M
Net Income towards Common Stockholders 2.71M-8.22M-13.60M-17.89M-19.56M-22.37M-37.92M
Additional items
EPS (Basic) 0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.08M0.08M0.46M0.48M1.65M9.37M25.60M
Shares Outstanding (Diluted Average) 4.30M0.48M1.39M18.36M
EBITDA 2.08M-8.36M-13.38M-18.00M-19.15M-21.81M-37.86M
Shares Outstanding 0.86M1.11M0.48M0.51M1.67M10.09M